Jefferies Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-409,400
| Closed | -$40.7M | – | 3284 |
|
|
2019
Q3 | $40.7M | Sell |
409,400
-641,500
| -61% | -$61M | 0.32% | 37 |
|
|
2019
Q2 | $97.1M | Sell |
1,050,900
-1,913,900
| -65% | -$182M | 0.71% | 11 |
|
|
2019
Q1 | $280M | Buy |
2,964,800
+2,561,300
| +635% | +$224M | 2.3% | 6 |
|
|
2018
Q4 | $25.9M | Sell |
403,500
-294,000
| -42% | -$21.7M | 0.21% | 68 |
|
|
2018
Q3 | $62.4M | Sell |
697,500
-14,800
| -2% | -$1.31M | 0.41% | 27 |
|
|
2018
Q2 | $56.6M | Buy |
712,300
+705,900
| +11,030% | +$58.6M | 0.32% | 36 |
|
|
2018
Q1 | $571K | Sell |
6,400
-91,300
| -93% | -$8.76M | ﹤0.01% | 1433 |
|
|
2017
Q4 | $10.2M | Buy |
97,700
+75,700
| +344% | +$8.54M | 0.05% | 303 |
|
|
2017
Q3 | $3.21M | Buy |
22,000
+9,900
| +82% | +$1.35M | 0.02% | 711 |
|
|
2017
Q2 | $1.57M | Sell |
12,100
-4,900
| -29% | -$600K | 0.01% | 1068 |
|
|
2017
Q1 | $2.12M | Sell |
17,000
-18,900
| -53% | -$2.26M | 0.02% | 878 |
|
|
2016
Q4 | $4.16M | Sell |
35,900
-27,900
| -44% | -$3.11M | 0.02% | 643 |
|
|
2016
Q3 | $6.67M | Buy |
63,800
+56,900
| +825% | +$6.16M | 0.03% | 430 |
|
|
2016
Q2 | $681K | Sell |
6,900
-99,600
| -94% | -$10.3M | ﹤0.01% | 1299 |
|
|
2016
Q1 | $10.7M | Sell |
106,500
-317,800
| -75% | -$32.7M | 0.06% | 246 |
|
|
2015
Q4 | $50.8M | Buy |
424,300
+244,500
| +136% | +$28.3M | 0.29% | 58 |
|
|
2015
Q3 | $19.4M | Buy |
179,800
+106,700
| +146% | +$13.2M | 0.11% | 144 |
|
|
2015
Q2 | $8.46M | Sell |
73,100
-8,700
| -11% | -$995K | 0.04% | 344 |
|
|
2015
Q1 | $9.43M | Buy |
81,800
+19,800
| +32% | +$2.37M | 0.05% | 254 |
|
|
2014
Q4 | $6.93M | Buy |
+62,000
| New | +$6.54M | 0.04% | 336 |
|
|
2013
Q3 | – | Sell |
-100,000
| Closed | -$5.85M | – | 2462 |
|
|
2013
Q2 | $5.85M | Buy |
+100,000
| New | +$6.02M | 0.06% | 223 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Jefferies Group's CELG Position: Q4 2019 in Review
Jefferies Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 577,965 shares — an estimated $57.4M sold.
Jefferies Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $57.4M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Jefferies Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Jefferies Group sold 577,965 Celgene Corp shares in Q4 2019, an estimated $57.4M.
- Jefferies Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Jefferies Group's Celgene Corp position peaked at $57.4M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.